nium-Responsive Proteins in the Sera of Selenium-iched Yeast – Supplemented Healthy African B & P erican and Caucasian

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Null Activity of Selenium and Vitamin E as Cancer Chemopreventive Agents in the Rat Prostate

  2010cited by this paper
• Selenomethionine and α-Tocopherol Do Not Inhibit Prostate Carcinogenesis in the Testosterone plus Estradiol–Treated NBL Rat Model

  2010cited by this paper
• Haptoglobin Expression in Endometrioid Adenocarcinoma of the Uterus

  2010cited by this paper
• Variants in blood pressure genes and the risk of renal cell carcinoma.

  2010cited by this paper
• The Negative Results of the SELECT Study Do Not Necessarily Discredit the Selenium-Cancer Prevention Hypothesis

  2009cited by this paper
• Potential stages for prostate cancer prevention with selenium: implications for cancer survivors.

  2009cited by this paper
• Advances and challenges in basic and translational research on clusterin.

  2009cited by this paper
• Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

  2009cited by this paper
• Clusterin (CLU) and prostate cancer.

  2009cited by this paper
• Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients

  2008cited by this paper
• Serum levels of variants of transthyretin down‐regulation in cholangiocarcinoma

  2008cited by this paper
• Effects of Naturally Occurring and Synthetic Organoselenium Compounds on Protein Profiling in Androgen Responsive and Androgen Independent Human Prostate Cancer Cells

  2008cited by this paper
• Targeting Clusterin in prostate cancer.

  2008cited by this paper
• Differential effects of naturally occurring and synthetic organoselenium compounds on biomarkers in androgen responsive and androgen independent human prostate carcinoma cells

  2007cited by this paper
• Chemoprevention of Prostate Cancer through Dietary Agents: Progress and Promise

  2007cited by this paper
• Inhibition of nuclear factor-kappaB DNA binding by organoselenocyanates through covalent modification of the p50 subunit.

  2007cited by this paper
• Reduced transthyretin expression in sera of lung cancer

  2007cited by this paper
• Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.

  2007cited by this paper
• Neural Network‐Based Analysis of Thiol Proteomics Data in Identifying Potential Selenium Targets

  2006cited by this paper
• Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study.

  2006cited by this paper
• Chromatofocusing fractionation and two‐dimensional difference gel electrophoresis for low abundance serum proteins

  2005cited by this paper
• Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility.

  2005cited by this paper
• Changes in Serum Proteomic Patterns by Presurgical α-Tocopherol and l-Selenomethionine Supplementation in Prostate Cancer

  2005cited by this paper
• Biomarkers for the detection and prognosis of prostate cancer

  2005cited by this paper
• Serum Proteomic Pattern Analysis for Early Cancer Detection

  2005cited by this paper
• Proteomic detection of prostate-specific antigen using a serum fractionation procedure: potential implication for new low-abundance cancer biomarkers detection.

  2005cited by this paper
• Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml.

  2004cited by this paper
• Lifestyle recommendations to prevent prostate cancer, part I: time to redirect our attention?

  2004cited by this paper
• Importance of serum amyloid A (SAA) level in monitoring disease activity and response to therapy in patients with prostate cancer

  2004cited by this paper
• Nutrition and cancer: A review of the evidence for an anti-cancer diet

  2004cited by this paper
• Functional Relationship and Gene Ontology Classification of Breast Cancer Biomarkers

  2003cited by this paper
• High‐throughput proteomic analysis of human infiltrating ductal carcinoma of the breast

  2003cited by this paper
• Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial.

  2002cited by this paper
• The relationship between reduced vitamin antioxidant concentrations and the systemic inflammatory response in patients with common solid tumours.

  2002cited by this paper
• Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer

  2002cited by this paper
• Proteomic analysis of human prostate cancer †

  2002cited by this paper
• Race and cause specific survival with prostate cancer: influence of clinical stage, Gleason score, age and treatment.

  2000cited by this paper
• Gene Ontology: tool for the unification of biology

  2000cited by this paper
• Proinflammatory cytokines and elastase-alpha-1-antitrypsin in Argentine hemorrhagic fever.

  1999cited by this paper
• Cytokines and Inflammatory Mediators Do Not Indicate Acute Infection in Cystic Fibrosis

  1999cited by this paper
• Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.

  1996cited by this paper
• Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database.

  1995cited by this paper
• The epidemiology of prostate cancer in black men.

  1992cited by this paper
• Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate

  1992cited by this paper
• Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.

  1991cited by this paper
• Cancer statistics

  1989cited by this paper
• Acute phase reactant proteins in prostatic cancer.

  1977cited by this paper
• Original Contribution Racial Differences in Serum Selenium Concentration: Analysis of Us Population Data from the Third National Health and Nutrition Examination Survey

  year unknowncited by this paper

• No citing papers are available for this paper.